Summit Therapeutics Inc. (SMMT) — SC 13D/A Filings

All SC 13D/A filings from Summit Therapeutics Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (1)

  • Duggan Amends Summit Therapeutics 13D Filing — Sep 13, 2024 Risk: medium
    Robert W. Duggan filed an amendment (No. 9) to Schedule 13D for Summit Therapeutics Inc. on September 13, 2024. The filing indicates a change in beneficial owne

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.